PRIMARY VECTOR
SYSTEMIC OPTIMIZATION
CLINICAL EFFICACY
DATA PENDING CLINICAL REVIEW
NCBI VERIFICATION
AWAITING PUBMED INDEX
WHAT IS IT?
A dual GIP and GLP-1 receptor agonist peptide engineered to alter metabolic function and gastric emptying.
WHAT DOES IT DO?
Forces extreme appetite suppression and re-sensitizes insulin receptors, leading to rapid fat loss.
HOW DO I USE IT?
Administered via weekly subcutaneous injections, titrated upward slowly over months.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
23Greg O'Gallagher
77.0